Trials / Conditions / Chronic Inducible Urticaria

Chronic Inducible Urticaria

10 registered clinical trials studyying Chronic Inducible Urticaria — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold I NCT07266402	Celldex Therapeutics	Phase 3
Recruiting	A Phase 1 Study of GTX-B001 in Healthy Subjects and Patients With Chronic Inducible Urticaria NCT07181369	Granular Therapeutics Limited	Phase 1
Recruiting	Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU) NCT06931405	Blueprint Medicines Corporation	Phase 2
Completed	A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible Urticaria NCT06603220	Evommune, Inc.	Phase 2
Terminated	A Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briqui NCT06353971	Jasper Therapeutics, Inc.	Phase 1 / Phase 2
Active Not Recruiting	A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With NCT05976243	Novartis Pharmaceuticals	Phase 3
Completed	Phase 1b, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects Wit NCT06050928	Escient Pharmaceuticals, Inc	Phase 1
Completed	A Single Dose, Phase 1 Study of YH35324 in Patients with Various Allergic Diseases NCT05960708	Yuhan Corporation	Phase 1
Completed	A Study of CDX-0159 in Patients With Chronic Inducible Urticaria NCT05405660	Celldex Therapeutics	Phase 2
Terminated	Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Rem NCT05024058	Novartis Pharmaceuticals	Phase 3